Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Nia Emami"'
Autor:
Nia Emami-Shahri, Julie Foster, Roxana Kashani, Patrycja Gazinska, Celia Cook, Jane Sosabowski, John Maher, Sophie Papa
Publikováno v:
Nature Communications, Vol 9, Iss 1, Pp 1-12 (2018)
Adoptive transfer of chimeric antigen receptor (CAR) T cells has shown promising anticancer results in clinical trials. Here the authors use the human sodium iodide symporter (hNIS) as a reporter gene to image human CAR T cells in cancer-bearing mice
Externí odkaz:
https://doaj.org/article/0d1c57bc0c364c149307c2471f782318
Autor:
Esther Drent, Sabine Middendorp, Andrea Bisso, Sjoerd Baardman, Dagmar Verweij, Estefania Salcedo, Chris Coomans, Steven Braem, Sander van de Weg, Menno Meijer, Natalie Proost, Marieke van de Ven, Haakan Norell, Marleen van Loenen, Nia Emami, Sara Melief, Stefania Gobessi, Mark Throsby
Publikováno v:
Regular and Young Investigator Award Abstracts.
Autor:
Patrycja Gazinska, Julie Foster, Roxana Kashani, John Maher, Sophie Papa, Jane K. Sosabowski, Nia Emami-Shahri, Celia Cook
Publikováno v:
Nature Communications, Vol 9, Iss 1, Pp 1-12 (2018)
Nature Communications
Emami-Shahri, N, Foster, J, Kashani, R, Gazinska, P, Cook, C, Maher, J, Sosabowski, J & Papa, S 2018, ' Clinically Compliant Spatial and Temporal Imaging of Chimeric Antigen Receptor T-cells ', Nature Communications, vol. 9, no. 1, 1081 . https://doi.org/10.1038/s41467-018-03524-1
Nature Communications
Emami-Shahri, N, Foster, J, Kashani, R, Gazinska, P, Cook, C, Maher, J, Sosabowski, J & Papa, S 2018, ' Clinically Compliant Spatial and Temporal Imaging of Chimeric Antigen Receptor T-cells ', Nature Communications, vol. 9, no. 1, 1081 . https://doi.org/10.1038/s41467-018-03524-1
The unprecedented efficacy of chimeric antigen receptor (CAR) T-cell immunotherapy of CD19+ B-cell malignancy has established a new therapeutic pillar of hematology–oncology. Nonetheless, formidable challenges remain for the attainment of comparabl
Autor:
Sophie Papa, Nia Emami-Shahri
Publikováno v:
Biochemical Society transactions. 44(2)
Chimaeric antigen receptor (CAR) therapy is entering the mainstream for the treatment of CD19+ cancers. As is does we learn more about resistance to therapy and the role, risks and management of toxicity. In solid tumour CAR therapy research the rout
Autor:
Thorsten Hagemann, Maud Bossard, Frances R. Balkwill, Sergei A. Nedospasov, Juliana Candido, Natalie Cook, Nia Emami-Shahri, David A. Tuveson, Eleni Maniati
Publikováno v:
Journal of Clinical Investigation. 121:4685-4699
The majority of human pancreatic cancers have activating mutations in the KRAS proto-oncogene. These mutations result in increased activity of the NF-κB pathway and the subsequent constitutive production of proinflammatory cytokines. Here, we show t
Publikováno v:
Cancer Research. 76:2315-2315
Immunotherapy using CAR-T-cells is acquiring an expanding role in the treatment of malignant disease. However, efficacy of solid tumour CAR-T-immunotherapy has proven inconsistent. Limitations include poor T-cell trafficking to tumour deposits, insuf
Autor:
Nia Emami-Shahri, Thorsten Hagemann
Publikováno v:
Rheumatology (Oxford, England). 51(3)
Biological therapeutics are widely used in chronic inflammatory and malignant disease. The underlying mechanisms of treatment failure for these drugs are poorly understood. Resistance to these biological agents and the further subdivision into intrin
Autor:
Ulf Petrausch, Sophie Papa, James Spicer, Gregory E. D. Mullen, Nia Emami-Shahri, John Maher, Zhe Liu
Publikováno v:
The Lancet. 383:S77
Background Chimeric antigen receptors (CARs) are fusion molecules that re-direct T-cell specificity against a selected cell surface target. Recent successes in the treatment of haematological malignancies using CD19-specific CAR T cells has moved thi
Publikováno v:
Cancer Research. 72:3209-3209
Nuclear factor-βB; (NF-κB) controls a range of genes involved in inflammation, cell survival, growth and apoptosis. The dysregulated NF-κB pathway has been found to be involved in carcinogenesis and cancer progression. An IKKα-deleted mouse pancr